Strategies for type-specific glycoconjugate vaccines of Streptococcus pneumoniae.
Arndt
B
B
Praxis Biologics Inc. Rochester, NY 14623.
Porro
M
M
D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001428:Bacterial Vaccines / Q000276:immunology / Q000302:isolation & purification*; D006001:Glycoconjugates / Q000737:chemistry / Q000276:immunology; D006241:Haptens / Q000737:chemistry / Q000276:immunology; D006801:Humans; D007120:Immunochemistry; D007074:Immunoglobulin G / Q000096:biosynthesis; D051379:Mice; D009844:Oligosaccharides / Q000737:chemistry / Q000276:immunology; D011817:Rabbits; D013296:Streptococcus pneumoniae / Q000276:immunology*
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D006001:Glycoconjugates; D006241:Haptens; D007074:Immunoglobulin G; D009844:Oligosaccharides